Combines Neon’s Personal Neoantigen Vaccine and Signatera (RUO) Circulating Tumor DNA Biomarker in Metastatic Non-Small Cell Lung Cancer Trial Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, and Neon Therapeutics, Inc. (NASDAQ: NTGN), a...
Nancy Crotti for Medical Design & Outsourcing writes (excerpted): Having a unified patient experience can also improve retention by resolving problems that could cause patient dropout or lack of usable trial data. When a patient’s digital health device indicates...
Excerpted from BMJ, Liming Lu, Yuqing Zhang, Gordon Guyatt, Chunzhi Tang, Nenggui Xu write: China has the potential to become one of the world’s most favoured sites for performing clinical trials.[1] Since 2008,[1] although China has seen a decline in the growth...
“There are a lot of new ways that we can use real world evidence to help inform regulatory decisions around medical products as the collection of this data gets more widespread and reliable. Better capture of real world data, collected from a variety of sources, has...
Excerpted from PMLive.com, There is increasing interest in digital trials, that is the use of mHealth and mobile technology to capture insights outside the traditional clinical setting. The drivers are clear – spiralling costs, questions with respect to existing...
Email
Text